학술논문

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01.
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS238-TPS238, 235p
Subject
Language
ISSN
0732183X